Randall H Gholson

Array ( [id] => 3889183 [patent_doc_number] => 05750078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => 1 [patent_app_number] => 8/408133 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 21482 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750078.pdf [firstpage_image] =>[orig_patent_app_number] => 408133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624516 [patent_doc_number] => 05620890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Monoclonal antibodies to hygromycin B and the method of making the same' [patent_app_type] => 1 [patent_app_number] => 8/404007 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6236 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620890.pdf [firstpage_image] =>[orig_patent_app_number] => 404007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598321 [patent_doc_number] => 05578306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Method for preventing embryo implantation' [patent_app_type] => 1 [patent_app_number] => 8/400270 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 22 [patent_no_of_words] => 6087 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578306.pdf [firstpage_image] =>[orig_patent_app_number] => 400270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858713 [patent_doc_number] => 05705614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Methods of producing antigen forks' [patent_app_type] => 1 [patent_app_number] => 8/396595 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 51 [patent_no_of_words] => 15772 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705614.pdf [firstpage_image] =>[orig_patent_app_number] => 396595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617725 [patent_doc_number] => 05593676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method of killing B cells using antibodies which bind CDIM' [patent_app_type] => 1 [patent_app_number] => 8/394673 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3410 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593676.pdf [firstpage_image] =>[orig_patent_app_number] => 394673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3632381 [patent_doc_number] => 05610058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells' [patent_app_type] => 1 [patent_app_number] => 8/351468 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2810 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610058.pdf [firstpage_image] =>[orig_patent_app_number] => 351468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658103 [patent_doc_number] => 05624659 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Method of treating brain tumors expressing tenascin' [patent_app_type] => 1 [patent_app_number] => 8/392419 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624659.pdf [firstpage_image] =>[orig_patent_app_number] => 392419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625885 [patent_doc_number] => 05608060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Biotinidase-resistant biotin-DOTA conjugates' [patent_app_type] => 1 [patent_app_number] => 8/351469 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 43202 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608060.pdf [firstpage_image] =>[orig_patent_app_number] => 351469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625093 [patent_doc_number] => 05602234 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Stable antibody solution and method for preparing same' [patent_app_type] => 1 [patent_app_number] => 8/387375 [patent_app_country] => US [patent_app_date] => 1995-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2129 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602234.pdf [firstpage_image] =>[orig_patent_app_number] => 387375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924498 [patent_doc_number] => 05876961 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Production of antibodies' [patent_app_type] => 1 [patent_app_number] => 8/378939 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16264 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876961.pdf [firstpage_image] =>[orig_patent_app_number] => 378939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848151 [patent_doc_number] => 05766920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Ex vivo activation of immune cells' [patent_app_type] => 1 [patent_app_number] => 8/370287 [patent_app_country] => US [patent_app_date] => 1995-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 11396 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766920.pdf [firstpage_image] =>[orig_patent_app_number] => 370287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837756 [patent_doc_number] => 05744318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples' [patent_app_type] => 1 [patent_app_number] => 8/367507 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10151 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744318.pdf [firstpage_image] =>[orig_patent_app_number] => 367507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884819 [patent_doc_number] => 05714333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Process for preparing clear sera which are stable over a long period' [patent_app_type] => 1 [patent_app_number] => 8/365019 [patent_app_country] => US [patent_app_date] => 1994-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4009 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714333.pdf [firstpage_image] =>[orig_patent_app_number] => 365019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777419 [patent_doc_number] => 05817771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Cell-targeted lytic pore-forming agents' [patent_app_type] => 1 [patent_app_number] => 8/364429 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 8026 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817771.pdf [firstpage_image] =>[orig_patent_app_number] => 364429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646018 [patent_doc_number] => 05629161 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Use of HVP-16 E6 and E7-gene derived peptides to diagnose HPV-16-associated invasive cervical cancer' [patent_app_type] => 1 [patent_app_number] => 8/363586 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3370 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629161.pdf [firstpage_image] =>[orig_patent_app_number] => 363586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626083 [patent_doc_number] => 05612458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Antibody to PNA/nucleic acid complexes' [patent_app_type] => 1 [patent_app_number] => 8/361643 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7553 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612458.pdf [firstpage_image] =>[orig_patent_app_number] => 361643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625538 [patent_doc_number] => 05608038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Highly concentrated immunoglobulin preparation and method for its production' [patent_app_type] => 1 [patent_app_number] => 8/359901 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1579 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608038.pdf [firstpage_image] =>[orig_patent_app_number] => 359901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831553 [patent_doc_number] => 05712157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Methods and materials for the immunoassay of apolipoprotein(a) and lipoprotein(a)' [patent_app_type] => 1 [patent_app_number] => 8/360234 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6693 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712157.pdf [firstpage_image] =>[orig_patent_app_number] => 360234 [rel_patent_id] =>[rel_patent_doc_number] =>)